The Valley Desk

NCT04592484 · Interventional trial

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Advanced Solid Tumor

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov